← 홈

Antibody

168개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 168개
AntibodyBiologicstaleNational Cancer Institute (NCI)Phase 1

Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor (AdHER, Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor, Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor (AdHER)2/neu Dendritic Cell (DC) Vaccine)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase1#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleRochePreclinical

trastuzumab (Herceptin, Ado-trastuzumab emtamsine)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleYuan YuanPhase 2

Balstilmab (Balstilmab)

Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Triple-Negative Breast Carcinoma · Anatomic Stage IV Breast Cancer AJCC v8

#AnatomicStageIVBreastCancerAJCCv#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Bevacizumab, Bevacizumab (drug), Herceptin (drug), drug)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
효능 ORR 73%임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Bevacizumab and trastuzumab maintenance therapy)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Bevacizumab maintenance therapy (Bevacizumab maintenance therapy)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Bevacizumab, docetaxel, cisplatin (Bevacizumab, docetaxel, cisplatin)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Bevacizumab,Trastuzumab,Paclitaxel,Cyclophosphamide,Myocet)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleMerckPhase 1

pembrolizumab (Keytruda, Bortezomib; pembrolizumab and cisplatin injections--bortezomib followed by pembro/cis)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleBiogenPhase 1

trastuzumab (Herceptin, CNF2024 + trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleBristol-Myers SquibbPhase 2

Cabiralizumab (Cabiralizumab)

Advanced Pancreatic Cancer · Triple Negative Breast Cancer

#TripleNegativeBreastCancer#Antibody#Phase2#항체#면역항체+3
효능 ORR 20%임상시험 1상태 ACTIVE
AntibodystaleSun Yat-Sen Memorial Hospital o…Preclinical

Camerlizumab (Camerlizumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleSouth Eastern European Research…Phase 2

Capecitabine and Bevacizumab (Capecitabine and Bevacizumab)

Breast Cancer; Metastasis · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleShandong Cancer Hospital and In…Phase 2

trastuzumab (Herceptin, Capecitabine,Trastuzumab, and Pertuzumab)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase2#항체#면역항체+2
효능 ORR 30%임상시험 1상태 ACTIVE
AntibodystaleThe Netherlands Cancer InstitutePhase 2

atezolizumab (Tecentriq, Carbo/cyclo + atezolizumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleFudan UniversityPhase 2

Carrelizumab (Carrelizumab)

Breast Neoplasm; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleSun Yat-sen UniversityPhase 3

trastuzumab (Herceptin, Chemotherapy combined with trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleKing Faisal Specialist Hospital…Preclinical

trastuzumab (Herceptin, Cisplatin-Docetaxel ± Trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleBaptist Health South FloridaPhase 1

trastuzumab (Herceptin, Combined use of SRS with Tucatinib, Trastuzumab, and Capecitabine)

Brain Metastases; HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase1#항체#면역항체+4
임상시험 1상태 DISCONTINUED
AntibodystaleFudan UniversityPhase 2

Cromolyn, TQB2102, and Panpulimab (Cromolyn, TQB2102, and Panpulimab)

Triple -Negative Breast Cancer · Triple -Negative Breast Cancer

#Triple-NegativeBreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING

3 / 9 페이지

← 이전다음 →